ARTICLE | Clinical News
Cartistem regulatory update
February 27, 2012 8:00 AM UTC
Medipost said the Korea Food and Drug Administration approved Cartistem to treat osteoarthritis. Cartistem consists of allogeneic mesenchymal stem cells from umbilical cord blood. The product is marke...